ICBEB 2021 was held online successfully via MS Teams during Nov. 15-18, 2021. Thanks for all the presenters and audiences. Hope to see you all physically next year. [November 19, 2021]

Considering the uncertainty caused by the global pandemic of COVID-19, ICBEB 2021 will go fully online via Microsoft Teams without physical attendance during November 15-18, 2021. [October 8, 2021]

Accepted papers from ICBEB, published online in Technology and Health Care (JCR IF 0.806), have been indexed by Science Citation Index Expanded.[May 12, 2021]

Accepted papers from ICBEB 2020 have been published online in Technology and Health Care (JCR IF 0.806). [April 8, 2021]

The 4th China Physiological Signal Challenge 2021-Paroxysmal Atrial Fibrillation Events Detection from Dynamic ECG Recordings is open. [March 20, 2021]

All accepted papers within the field of Biomechanics and Biomechanical Engineering from ICBEB 2020 have been published and indexed by Science Citation Index Expanded. [February 20, 2021]

Accepted abstracts from ICBEB 2020, published in Basic & Clinical Pharmacology & Toxicology (JCR IF 2.651), have been indexed by Science Citation Index Expanded two weeks after publication. [November 26, 2020]

ICBEB 2020 is successfully held via MS Teams during November 15-18, 2020 with online attendees from over 20 countries and regions. CPSC 2020 has also ended in success. [November 19, 2020]

ICBEB 2021 proposes a Special Session entitled H2020 BAMOS - Biomaterials and Additive Manufacturing for early intervention of osteoarthritis.

Proposers:
Prof. Chaozong Liu, University College London, The Royal National Orthopaedic Hospital, UK
Prof. Ling Wang, Xi’an Jiaotong University, China

Scope
Osteoarthritis (OA) is a degenerative joint disease, typified by a loss of quality of cartilage and changes in bone at the interface of a joint, resulting in pain, stiffness and reduced mobility. H2020 BAMOS project aims to establish and embed a new collaboration between six internationally leading research organizations (four universities, one healthcare provider and one manufacturer with expertise in additive manufacturing) in addressing the challenges in OA treatment by providing novel cost effective osteochondral scaffold technology for early intervention of OA to delay or avoid the joint replacement operations by develop new materials and manufacturing technologies for the fabrication of custom-tailored osteochondral scaffolds. This session is to share the achievement of the BAMOS project within TERMIS community, and interact with colleagues who have the same interest in early OA intervention.

Please visit http://www.icbeb.org/SpecialSession for more details on the Special Session-H2020 BAMOS.